http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101678710-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-72 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-76 |
filingDate | 2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101678710-B1 |
titleOfInvention | Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug |
abstract | The present invention relates to novel imidazolidin-2,4-dione derivatives of formula (I) The substance has antiproliferative activity. They are particularly useful for the treatment of pathological conditions and diseases associated with abnormal cell proliferation, such as cancer. The invention also relates to a pharmaceutical composition containing said substance and its use in the manufacture of a medicament. (I) (Wherein R 1 , R 2 , R 3 , R 4 , X and Y are variable groups) |
priorityDate | 2009-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 319.